tag sanofi-1 
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. For example, in Sweden, the proposed arrangement for Sanofi / Regeneron’s Dupixent (dupilumab) included a tripartite price negotiation involving Sanofi, the Dental and Pharmaceutical Benefits Agency (Tandvårds- och läkemedelsförmånsverket, TLV), and local councils.
Pharmaceutical Technology
MAY 15, 2023
Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.
PM360
APRIL 7, 2023
The shift toward longer, more adequate timeframes to establish proof of concept can be as long as three to four years, 1 given the complex requirements for developing and launching specialty drugs and cell and gene therapies (CGTs) for individuals with complex conditions or rare or orphan diseases. References: 1. Naddaf, Miryam. “$3.5-Million
Expert insights. Personalized for you.
105 
Let's personalize your content